The effect of extracorporeal photochemotherapy on α1(I) and α1(III) procollagen mRNA expression in systemic sclerosis skin tissue

Archives of Dermatological Research

Volumn 293, Issue 12, 2002, Pages 642-645

  Ohtsuka, Tsutomu ^a   Okita, Hiroshi ^a   Yamakage, Akio ^a   Yamazaki, Soji ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

(I) and 1(III) procollagen mRNA; Extracorporeal photochemotherapy; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; DNA ANTIBODY; ISOPROTEIN; MESSENGER RNA; METHOXSALEN; PENICILLAMINE; PROCOLLAGEN; SINGLE STRANDED DNA;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; COLLAGEN SYNTHESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; EXTRACELLULAR MATRIX; EXTRACORPOREAL CIRCULATION; FEMALE; FINGER; FOREARM; HAND MOVEMENT; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LABORATORY TEST; LUNG FIBROSIS; MALE; MULTICENTER STUDY; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUVA; QUANTITATIVE ANALYSIS; SKIN BIOPSY; SKIN EDEMA; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; COLLAGEN TYPE I; COLLAGEN TYPE III; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOPHERESIS; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; SKIN;

EID: 0035726453     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-001-0287-6     Document Type: Article

References (12)

1. Photopheresis: A new therapeutic concept
2. Treatment of systemic sclerosis
3. SSc (systemic sclerosis): Classification, subsets and pathogenesis
4. Quantitative analysis of α1(I) and α1(III) procollagen mRNA expression in systemic sclerosis skin tissue - An in situ hybridization study
5. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial
6. The discrepancy in hardness between clinical and histopathological findings in localized scleroderma treated with PUVA
7. Photopheresis: A clinically relevant immunobiologic response modifier
8. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: Implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis
9. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma
10. Scleroderma fibroblasts show increased responsiveness to endothelial cell-derived IL-1 and bFGF
11. Growth regulation in scleroderma fibroblasts: Increased response to transforming growth factor-beta 1